http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6550496

Outgoing Links

Predicate Object
contentType Comparative Study|Journal Article|Research Support, Non-U.S. Gov't|Review|Systematic Review
issn 1756-9966
0392-9078
issueIdentifier 1
pageRange 21-
publicationName Journal of experimental & clinical cancer research : CR
startingPage 21
bibliographicCitation Akl EA, Barba M, Rohilla S, Terrenato I, Sperati F, Muti P, Schünemann HJ. Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review. Journal of Experimental & Clinical Cancer Research. 2008 Jul 18;27(1):21. doi: 10.1186/1756-9966-27-21.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6581a39ba1c67b2350aaa95a783c2015
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5c28f7a32a9fe2f17f18d0c010620f34
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9050-2917
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6038-2798
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_63c3d717aba8ab089d4dc4fe61f74729
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0187-9323
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_48b2333574d4dfb7ff1a2c2bce20922a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_079a5fc21f8c437babe7b54aec4053b9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_806633c7417a9fa84ecf1e7a75afdee6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7f3a7c98376adbf24530cf3b72209776
date 2008-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1186/1756-9966-27-21
https://pubmed.ncbi.nlm.nih.gov/PMC2507703
https://pubmed.ncbi.nlm.nih.gov/18634550
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20601
https://portal.issn.org/resource/ISSN/0392-9078
https://portal.issn.org/resource/ISSN/1756-9966
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/
title Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review
discusses http://id.nlm.nih.gov/mesh/M0010191
http://id.nlm.nih.gov/mesh/M0022806
http://id.nlm.nih.gov/mesh/M0001380
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9574101
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5478933
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280483
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93971978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73101855
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID772
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4812
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656635

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136116304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128926582
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248153327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID245255101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129445304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129972330

Total number of triples: 53.